[1]
“Modern possibilities of targeted therapy in the treatment of breast cancer patients with overexpression of HER-2/neu and metastatic damage of the brain”, Вопр. онкол., vol. 59, no. 3, pp. 347–351, Dec. 2013, doi: 10.37469/0507-3758-2013-59-3-347-351.